Phase I Study of Oral ZIO-101-C in Advanced Solid Tumors and Lymphomas

NCT00592163 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors
Lymphomas

Interventions

DRUG: ZIO-101-C (Darinaparsin)

Sponsor

Alaunos Therapeutics